Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Magro

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|December 20, 2011
Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionMichael Magro, Sjoerd T Nauta, Cihan Simsek, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein graftsMasanori Taniwaki, Lorenz Räber, Michael Magro, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysisMichael Magro, Joanna Wykrzykowska, Patrick W Serruys, et al.
Heart (British Cardiac Society)|August 29, 2014
Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEFNick van Boven, Stephan Windecker, Victor A Umans, et al.
American Heart Journal|April 9, 2011
Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore studyMichael Magro, Sjoerd Nauta, Cihan Simsek, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2011
Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass graftsSjoerd T Nauta, Nicolas M Van Mieghem, Michael Magro, et al.
European Heart Journal|November 24, 2011
Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical applicationVasim Farooq, Bill D Gogas, Takayuki Okamura, et al.
Journal of the American Heart Association|April 26, 2021
Quantitative Flow Ratio to Predict Nontarget Vessel-Related Events at 5 Years in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Angiography-Guided RevascularizationSarah Bär, Raminta Kavaliauskaite, Yasushi Ueki, et al.
International Journal of Cardiology|June 3, 2014
The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trialMichael Magro, Lorenz Räber, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 30, 2013
Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registryMichael Magro, Chrysafios Girasis, Antonio L Bartorelli, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|December 20, 2011
Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionMichael Magro, Sjoerd T Nauta, Cihan Simsek, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein graftsMasanori Taniwaki, Lorenz Räber, Michael Magro, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysisMichael Magro, Joanna Wykrzykowska, Patrick W Serruys, et al.
Heart (British Cardiac Society)|August 29, 2014
Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEFNick van Boven, Stephan Windecker, Victor A Umans, et al.
American Heart Journal|April 9, 2011
Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore studyMichael Magro, Sjoerd Nauta, Cihan Simsek, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2011
Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass graftsSjoerd T Nauta, Nicolas M Van Mieghem, Michael Magro, et al.
European Heart Journal|November 24, 2011
Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical applicationVasim Farooq, Bill D Gogas, Takayuki Okamura, et al.
Journal of the American Heart Association|April 26, 2021
Quantitative Flow Ratio to Predict Nontarget Vessel-Related Events at 5 Years in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Angiography-Guided RevascularizationSarah Bär, Raminta Kavaliauskaite, Yasushi Ueki, et al.
International Journal of Cardiology|June 3, 2014
The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trialMichael Magro, Lorenz Räber, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 30, 2013
Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registryMichael Magro, Chrysafios Girasis, Antonio L Bartorelli, et al.
Pageof 7